JP7050054B2 - Pde4阻害剤としての縮合環系化合物 - Google Patents
Pde4阻害剤としての縮合環系化合物 Download PDFInfo
- Publication number
- JP7050054B2 JP7050054B2 JP2019510933A JP2019510933A JP7050054B2 JP 7050054 B2 JP7050054 B2 JP 7050054B2 JP 2019510933 A JP2019510933 A JP 2019510933A JP 2019510933 A JP2019510933 A JP 2019510933A JP 7050054 B2 JP7050054 B2 JP 7050054B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- alkyl
- mmol
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610706073 | 2016-08-22 | ||
| CN201610706073.1 | 2016-08-22 | ||
| PCT/CN2017/098462 WO2018036470A1 (zh) | 2016-08-22 | 2017-08-22 | 作为pde4抑制剂的并环类化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529364A JP2019529364A (ja) | 2019-10-17 |
| JP2019529364A5 JP2019529364A5 (cg-RX-API-DMAC10.html) | 2020-08-06 |
| JP7050054B2 true JP7050054B2 (ja) | 2022-04-07 |
Family
ID=61246426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510933A Active JP7050054B2 (ja) | 2016-08-22 | 2017-08-22 | Pde4阻害剤としての縮合環系化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10532986B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3502099B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7050054B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN109563051B (cg-RX-API-DMAC10.html) |
| ES (1) | ES2852098T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018036470A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7237973B2 (ja) * | 2018-01-29 | 2023-03-13 | メッドシャイン ディスカバリー インコーポレイテッド | 1H-イミダゾ[4,5-b]ピリジン-2(3H)-オン系化合物の結晶形及びその製造方法 |
| WO2021000934A1 (zh) * | 2019-07-04 | 2021-01-07 | 南京明德新药研发有限公司 | 一种苯并咪唑-2-酮类化合物的晶型、溶剂化物、溶剂化物的晶型及它们的制备方法 |
| EP4101848A4 (en) * | 2020-02-24 | 2023-07-26 | Suzhou Longbotai Pharmaceuticals Co., Ltd. | Pde4 inhibitor compound and medical use thereof |
| CN116783181B (zh) * | 2021-04-12 | 2026-01-30 | 上海瑛派药业有限公司 | 取代的稠合双环类化合物作为parp抑制剂及其应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004526727A (ja) | 2001-03-09 | 2004-09-02 | ファイザー・プロダクツ・インク | ベンゾイミダゾール抗炎症化合物 |
| JP2014114308A (ja) | 2014-01-31 | 2014-06-26 | Celgene Corp | (+)−2−[1−(3−エトキシ−4−メトキシフェニル)−2−メチルスルホニルエチル]−4−アセチルアミノイソインドリン−1,3−ジオンを含む固形物形態、その組成物およびその使用 |
| WO2016008593A1 (en) | 2014-07-16 | 2016-01-21 | Grünenthal GmbH | Novel substituted pyrimidine compounds |
| JP2016507581A (ja) | 2013-02-19 | 2016-03-10 | ファイザー・インク | Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 |
| JP2016523259A (ja) | 2013-06-21 | 2016-08-08 | ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. | 新規の二環式ブロモドメイン阻害剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115644B2 (en) * | 2002-09-13 | 2006-10-03 | Boehringer Ingelheim Pharmaceuticals Inc. | Heterocyclic compounds |
| US8119676B2 (en) * | 2006-08-26 | 2012-02-21 | Abbott GmbH & Co. HG | Substituted benzimidazolone derivatives, medicaments comprising them and their use |
| WO2011021678A1 (ja) * | 2009-08-21 | 2011-02-24 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| EP2603079B1 (en) * | 2010-08-12 | 2018-09-19 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mglur2 |
-
2017
- 2017-08-22 WO PCT/CN2017/098462 patent/WO2018036470A1/zh not_active Ceased
- 2017-08-22 CN CN201780046018.7A patent/CN109563051B/zh active Active
- 2017-08-22 JP JP2019510933A patent/JP7050054B2/ja active Active
- 2017-08-22 EP EP17842893.4A patent/EP3502099B1/en active Active
- 2017-08-22 US US16/325,626 patent/US10532986B2/en active Active
- 2017-08-22 ES ES17842893T patent/ES2852098T3/es active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004526727A (ja) | 2001-03-09 | 2004-09-02 | ファイザー・プロダクツ・インク | ベンゾイミダゾール抗炎症化合物 |
| JP2016507581A (ja) | 2013-02-19 | 2016-03-10 | ファイザー・インク | Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 |
| JP2016523259A (ja) | 2013-06-21 | 2016-08-08 | ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. | 新規の二環式ブロモドメイン阻害剤 |
| JP2014114308A (ja) | 2014-01-31 | 2014-06-26 | Celgene Corp | (+)−2−[1−(3−エトキシ−4−メトキシフェニル)−2−メチルスルホニルエチル]−4−アセチルアミノイソインドリン−1,3−ジオンを含む固形物形態、その組成物およびその使用 |
| WO2016008593A1 (en) | 2014-07-16 | 2016-01-21 | Grünenthal GmbH | Novel substituted pyrimidine compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3502099A4 (en) | 2020-03-04 |
| US10532986B2 (en) | 2020-01-14 |
| EP3502099B1 (en) | 2020-12-09 |
| CN109563051B (zh) | 2024-06-11 |
| US20190210975A1 (en) | 2019-07-11 |
| WO2018036470A1 (zh) | 2018-03-01 |
| JP2019529364A (ja) | 2019-10-17 |
| ES2852098T3 (es) | 2021-09-13 |
| CN109563051A (zh) | 2019-04-02 |
| EP3502099A1 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6617155B6 (ja) | チロシンキナーゼ阻害剤およびそれを含む医薬組成物 | |
| JP6774578B2 (ja) | Mek阻害剤としてのクマリン環系化合物およびその応用。 | |
| CN112839655B (zh) | 甲状腺激素受体β促效剂化合物 | |
| IL293962B1 (en) | Kras mutant protein inhibitors | |
| CN113286794A (zh) | Kras突变蛋白抑制剂 | |
| JP7029444B2 (ja) | Pde4阻害剤 | |
| WO2021041237A1 (en) | Thyroid hormone receptor beta agonist compounds | |
| EP4206197B1 (en) | Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method | |
| EP3459942A1 (en) | Dna-pk inhibitors | |
| CN104860931A (zh) | 丙肝病毒抑制剂及其制药用途 | |
| JP7237010B2 (ja) | Hdac6選択的阻害剤およびその製造方法と使用 | |
| JP6836693B2 (ja) | A2a受容体アンタゴニストとしての縮合環誘導体 | |
| CA3054324C (en) | Tri-cycle compound and applications thereof | |
| JP2023505850A (ja) | サイクリン依存性キナーゼ9阻害剤としての化合物及びその用途 | |
| CN109563051B (zh) | 作为pde4抑制剂的并环类化合物 | |
| KR102547709B1 (ko) | 아제티딘 유도체 | |
| JP6883882B2 (ja) | S1p1アゴニスト及びその応用 | |
| CN114907385A (zh) | 氮杂芳基化合物、其制备方法及应用 | |
| JP6900406B2 (ja) | Akt阻害剤としてのジヒドロピラゾロアゼピン系化合物 | |
| JP7358372B2 (ja) | イミダゾピロロン化合物及びその使用 | |
| JP2019524810A (ja) | 抗hcmvウイルス化合物 | |
| JP2024516194A (ja) | Pd1/pd-l1阻害剤としての化合物及びその方法 | |
| HK40085073A (en) | Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method | |
| EA038176B1 (ru) | Производные пирроло-[1,2,5]бензотиадиазепина и их применение для лечения заболевания, вызванного вирусом гепатита в | |
| HK40012431B (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200625 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200625 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210713 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211013 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211109 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220308 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220328 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7050054 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |